1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Oral Clinical Nutrition Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Oral Clinical Nutrition Market Revenue and Volume, by Stage
8.1.1 Adults
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Pediatrics
8.1.2.1. Market Revenue and Volume Forecast
9.1. Oral Clinical Nutrition Market Revenue and Volume, by Indication
9.1.1. Alzheimer’s
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Nutrition Deficiency
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Cancer Care
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Diabetes
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Chronic Kidney Diseases
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Orphan Diseases
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Dysphagia
9.1.7.1. Market Revenue and Volume Forecast
9.1.8. Pain Management
9.1.8.1. Market Revenue and Volume Forecast
9.1.9. Malabsorption/GI Disorder/Diarrhea
9.1.9.1. Market Revenue and Volume Forecast
10.1. Oral Clinical Nutrition Market Revenue and Volume, by Sales Channel
10.1.1. Online Sales
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Retail Sales
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Institutional Sales
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Stage
11.1.2. Market Revenue and Volume Forecast, by Indication
11.1.3. Market Revenue and Volume Forecast, by Sales Channel
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Stage
11.1.4.2. Market Revenue and Volume Forecast, by Indication
11.1.4.3. Market Revenue and Volume Forecast, by Sales Channel
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Stage
11.1.5.2. Market Revenue and Volume Forecast, by Indication
11.1.5.3. Market Revenue and Volume Forecast, by Sales Channel
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Stage
11.2.2. Market Revenue and Volume Forecast, by Indication
11.2.3. Market Revenue and Volume Forecast, by Sales Channel
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Stage
11.2.4.2. Market Revenue and Volume Forecast, by Indication
11.2.4.3. Market Revenue and Volume Forecast, by Sales Channel
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Stage
11.2.5.2. Market Revenue and Volume Forecast, by Indication
11.2.5.3. Market Revenue and Volume Forecast, by Sales Channel
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Stage
11.2.6.2. Market Revenue and Volume Forecast, by Indication
11.2.6.3. Market Revenue and Volume Forecast, by Sales Channel
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Stage
11.2.7.2. Market Revenue and Volume Forecast, by Indication
11.2.7.3. Market Revenue and Volume Forecast, by Sales Channel
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Stage
11.3.2. Market Revenue and Volume Forecast, by Indication
11.3.3. Market Revenue and Volume Forecast, by Sales Channel
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Stage
11.3.4.2. Market Revenue and Volume Forecast, by Indication
11.3.4.3. Market Revenue and Volume Forecast, by Sales Channel
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Stage
11.3.5.2. Market Revenue and Volume Forecast, by Indication
11.3.5.3. Market Revenue and Volume Forecast, by Sales Channel
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Stage
11.3.6.2. Market Revenue and Volume Forecast, by Indication
11.3.6.3. Market Revenue and Volume Forecast, by Sales Channel
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Stage
11.3.7.2. Market Revenue and Volume Forecast, by Indication
11.3.7.3. Market Revenue and Volume Forecast, by Sales Channel
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Stage
11.4.2. Market Revenue and Volume Forecast, by Indication
11.4.3. Market Revenue and Volume Forecast, by Sales Channel
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Stage
11.4.4.2. Market Revenue and Volume Forecast, by Indication
11.4.4.3. Market Revenue and Volume Forecast, by Sales Channel
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Stage
11.4.5.2. Market Revenue and Volume Forecast, by Indication
11.4.5.3. Market Revenue and Volume Forecast, by Sales Channel
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Stage
11.4.6.2. Market Revenue and Volume Forecast, by Indication
11.4.6.3. Market Revenue and Volume Forecast, by Sales Channel
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Stage
11.4.7.2. Market Revenue and Volume Forecast, by Indication
11.4.7.3. Market Revenue and Volume Forecast, by Sales Channel
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Stage
11.5.2. Market Revenue and Volume Forecast, by Indication
11.5.3. Market Revenue and Volume Forecast, by Sales Channel
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Stage
11.5.4.2. Market Revenue and Volume Forecast, by Indication
11.5.4.3. Market Revenue and Volume Forecast, by Sales Channel
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Stage
11.5.5.2. Market Revenue and Volume Forecast, by Indication
11.5.5.3. Market Revenue and Volume Forecast, by Sales Channel
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Pfizer Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bayer AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Nestle S.A.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. GlaxoSmithKline plc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Baxter International Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Otsuka Holdings Co., Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Mead Johnson & Company, LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Danone Nutricia, Victus, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
